GlassScriptPhysician profile
Ivy N Todd
NPI 1871914366
$3,442.69
in general payments reported to CMS, 2019-2025
24 companies · $551 in 2025
The $551 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $886 · 2022: $1,018 · 2023: $358 · 2024: $630 · 2025: $551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,538.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,238.78 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $510.72 | 2021-2025 | |
| Preventric Diagnostics, INC. | $373.72 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $191.61 | 2021-2025 | Airsupra, Farxiga |
| Lilly USA, LLC | $167.50 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $126.14 | 2021-2022 | |
| Amgen INC. | $113.03 | 2021-2023 | Otezla, Repatha |
| Ibsa Pharma INC. | $107.45 | 2021-2024 | Tirosint, Tirosint, Licart |
| Pfizer INC. | $93.05 | 2021-2025 | |
| Cranial Technologies, INC | $77.20 | 2021-2025 | Doc Band |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.92 | 2021-2022 | |
| Exact Sciences Corporation | $55.08 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $52.70 | 2021-2025 | Capvaxive, Gardasil 9, Enflonsia |
| Amarin Pharma, INC. | $51.96 | 2021 | |
| Phadia US INC. | $51.02 | 2021-2024 | Immunocap |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $24.77 | 2022 | |
| Glaxosmithkline, LLC. | $23.67 | 2021 | |
| Amneal Pharmaceuticals LLC | $22.88 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.05 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $18.33 | 2021 | |
| Boston Scientific Corporation | $18.13 | 2021 | |
| Acella Pharmaceuticals, LLC | $15.90 | 2023 | NP Thyroid 60 |
| Azurity Pharmaceuticals, INC. | $14.60 | 2023 | Adthyza |
| Kowa Pharmaceuticals America, INC. | $13.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivy Todd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.